The countries consist of nearly all low-income and lower-middle income ones, as well as several that are upper-middle- and high-income, the drugmaker said. Afghanistan, India, North Korea, Pakistan and South Africa are among the countries.

The licensees will also set their own prices for the generic product they produce, Gilead said.

The licenses are royalty-free until the World Health Organization declares the end of the public health emergency regarding COVID-19, or until a product other than remdesivir or a vaccine is approved to treat or prevent COVID-19, the company said.

Aon sets up MGA with world’s largest capacity for Intellectual Property Liability Risks

May 11, 2020

It is the latest offering from Aon to meet the changing needs of clients’ intellectual property (IP) exposures, especially in this distressed economic environment.Target markets include businesses of all sizes from SMEs to multi-national corporations in North America, Europe, Australia, New Zealand and parts of Asia

-Primary limit of indemnity of up to $100 million (€100 million)

South Korea reports 34 new coronavirus cases,highest in a month

May 10, 2020

China’s National Health Commission reported 14 new confirmed coronavirus cases on May 9, the highest number since April 28, including the first for more than a month in the city of Wuhan where the outbreak was first detected late last year.

Iran-linked hackers recently targeted coronavirus drugmaker Gilead

May 10, 2020

Britain and the United States warned this week that state-backed hackers are attacking pharmaceutical companies and research institutions working on treatments for the new disease.

« Older Entries

Next Entries »

Briefs